Kendra Adams

Insider Reports History

Location
Watertown, MA
Signature
/s/ Shagha Russell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kendra Adams:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Financial Officer Common Stock 385,098 $727,835 $1.89 14 Feb 2026 Direct
C4 Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 130,600 14 Feb 2025 Direct

Insider Reports Filed by Kendra Adams

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 13 Feb 2026 5 -$32,591 4 Chief Financial Officer 18 Feb 2026, 17:04
CCCC C4 Therapeutics, Inc. 18 Sep 2025 2 -$9,213 4 Chief Financial Officer 19 Sep 2025, 16:13
CCCC C4 Therapeutics, Inc. 13 Feb 2025 4 -$20,459 4 Chief Financial Officer 18 Feb 2025, 16:54
CCCC C4 Therapeutics, Inc. 07 Nov 2024 3 -$6,656 4 Chief Financial Officer 12 Nov 2024, 16:17
CCCC C4 Therapeutics, Inc. 18 Sep 2024 1 -$11,720 4 Chief Financial Officer 20 Sep 2024, 16:13
CCCC C4 Therapeutics, Inc. 16 Sep 2024 3 -$4,204 4 Chief Financial Officer 17 Sep 2024, 17:12
CCCC C4 Therapeutics, Inc. 07 Mar 2024 2 $0 4 Chief Financial Officer 08 Mar 2024, 19:21
CCCC C4 Therapeutics, Inc. 13 Feb 2024 3 -$8,496 4 Chief Financial Officer 15 Feb 2024, 17:02
CCCC C4 Therapeutics, Inc. 18 Sep 2023 2 $0 4 Chief Financial Officer 19 Sep 2023, 19:21
CCCC C4 Therapeutics, Inc. 18 Sep 2023 0 $0 3 Chief Financial Officer 19 Sep 2023, 19:20